Cargando…
Liver-inclusive intestinal transplantation results in decreased alloimmune-mediated rejection but increased infection
BACKGROUND AND AIMS: A co-transplanted liver allograft has been thought to protect other organs from rejection-mediated injury; however, detailed analyses of co-transplanted liver on intestinal allograft outcomes have not been conducted to date. The aim of the study was to compare immune-mediated in...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806397/ https://www.ncbi.nlm.nih.gov/pubmed/29479440 http://dx.doi.org/10.1093/gastro/gox043 |
_version_ | 1783299123780255744 |
---|---|
author | Wu, Guosheng Cruz, Ruy J |
author_facet | Wu, Guosheng Cruz, Ruy J |
author_sort | Wu, Guosheng |
collection | PubMed |
description | BACKGROUND AND AIMS: A co-transplanted liver allograft has been thought to protect other organs from rejection-mediated injury; however, detailed analyses of co-transplanted liver on intestinal allograft outcomes have not been conducted to date. The aim of the study was to compare immune-mediated injury, causes of graft failure and clinical outcomes between recipients who underwent either a liver-inclusive intestinal transplant (LITx) or liver-exclusive intestinal transplant (LETx). METHODS: Between May 2000 and May 2010, 212 adult patients undergoing LITx (n =76) and LETx (n =136) were included. LITx underwent either liver combined intestinal or full multivisceral transplantation. LETx underwent either isolated intestinal or modified multivisceral transplantation. RESULTS: During 44.9 ± 31.4 months of follow-up, death-censored intestinal graft survival was significantly higher for LITx than LETx (96.9%, 93.2% and 89.9% vs 91.4%, 69.3% and 60.0% at 1, 3 and 5 years; p =0.0001). Incidence of graft loss due to rejection was higher in LETx than in LITx (30.9% vs 6.6%; p <0.0001), while infection was the leading cause of graft loss due to patient death in LITx (25.0% vs 5.1%; p <0.0001). Despite similar immunosuppression, the average number (0.87 vs 1.42, p =0.02) and severity of acute cellular rejection episode (severe grade: 7.9% vs 21.3%; p =0.01) were lower in LITx than in LETx. Incidence of acute antibody-mediated rejection was also significantly lower in LITx than in LETx (3.6% vs 15.2%; p =0.03). Incidence of chronic rejection was reduced in LITx (3.9% vs 24.3%; p =0.0002). CONCLUSIONS: Intestinal allografts with a liver component appear to decrease risk of rejection but increase risk of infection. Our findings emphasize that LITx has characteristic immunologic and clinical features. Lower immunosuppression may need to be considered for patients who undergo LITx to attenuate increased risk of infection. |
format | Online Article Text |
id | pubmed-5806397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58063972018-02-23 Liver-inclusive intestinal transplantation results in decreased alloimmune-mediated rejection but increased infection Wu, Guosheng Cruz, Ruy J Gastroenterol Rep (Oxf) Original Articles BACKGROUND AND AIMS: A co-transplanted liver allograft has been thought to protect other organs from rejection-mediated injury; however, detailed analyses of co-transplanted liver on intestinal allograft outcomes have not been conducted to date. The aim of the study was to compare immune-mediated injury, causes of graft failure and clinical outcomes between recipients who underwent either a liver-inclusive intestinal transplant (LITx) or liver-exclusive intestinal transplant (LETx). METHODS: Between May 2000 and May 2010, 212 adult patients undergoing LITx (n =76) and LETx (n =136) were included. LITx underwent either liver combined intestinal or full multivisceral transplantation. LETx underwent either isolated intestinal or modified multivisceral transplantation. RESULTS: During 44.9 ± 31.4 months of follow-up, death-censored intestinal graft survival was significantly higher for LITx than LETx (96.9%, 93.2% and 89.9% vs 91.4%, 69.3% and 60.0% at 1, 3 and 5 years; p =0.0001). Incidence of graft loss due to rejection was higher in LETx than in LITx (30.9% vs 6.6%; p <0.0001), while infection was the leading cause of graft loss due to patient death in LITx (25.0% vs 5.1%; p <0.0001). Despite similar immunosuppression, the average number (0.87 vs 1.42, p =0.02) and severity of acute cellular rejection episode (severe grade: 7.9% vs 21.3%; p =0.01) were lower in LITx than in LETx. Incidence of acute antibody-mediated rejection was also significantly lower in LITx than in LETx (3.6% vs 15.2%; p =0.03). Incidence of chronic rejection was reduced in LITx (3.9% vs 24.3%; p =0.0002). CONCLUSIONS: Intestinal allografts with a liver component appear to decrease risk of rejection but increase risk of infection. Our findings emphasize that LITx has characteristic immunologic and clinical features. Lower immunosuppression may need to be considered for patients who undergo LITx to attenuate increased risk of infection. Oxford University Press 2018-02 2017-12-28 /pmc/articles/PMC5806397/ /pubmed/29479440 http://dx.doi.org/10.1093/gastro/gox043 Text en © The Author(s) 2017. Published by Oxford University Press and Sixth Affiliated Hospital of Sun Yat-Sen University http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Articles Wu, Guosheng Cruz, Ruy J Liver-inclusive intestinal transplantation results in decreased alloimmune-mediated rejection but increased infection |
title | Liver-inclusive intestinal transplantation results in decreased alloimmune-mediated rejection but increased infection |
title_full | Liver-inclusive intestinal transplantation results in decreased alloimmune-mediated rejection but increased infection |
title_fullStr | Liver-inclusive intestinal transplantation results in decreased alloimmune-mediated rejection but increased infection |
title_full_unstemmed | Liver-inclusive intestinal transplantation results in decreased alloimmune-mediated rejection but increased infection |
title_short | Liver-inclusive intestinal transplantation results in decreased alloimmune-mediated rejection but increased infection |
title_sort | liver-inclusive intestinal transplantation results in decreased alloimmune-mediated rejection but increased infection |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806397/ https://www.ncbi.nlm.nih.gov/pubmed/29479440 http://dx.doi.org/10.1093/gastro/gox043 |
work_keys_str_mv | AT wuguosheng liverinclusiveintestinaltransplantationresultsindecreasedalloimmunemediatedrejectionbutincreasedinfection AT cruzruyj liverinclusiveintestinaltransplantationresultsindecreasedalloimmunemediatedrejectionbutincreasedinfection |